Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) closed at $7.61 up 2.15% from its previous closing price of $7.45. In other words, the price has increased by $2.15 from its previous closing price. On the day, 3.13 million shares were traded. BCRX stock price reached its highest trading level at $7.79 during the session, while it also had its lowest trading level at $7.41.
Ratios:
For a deeper understanding of Biocryst Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.73 and its Current Ratio is at 2.78.
On September 18, 2023, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $9 to $10.
Jefferies Upgraded its Hold to Buy on August 04, 2023, while the target price for the stock was maintained at $11.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 13 ’24 when Hutson Nancy J sold 7,000 shares for $7.54 per share. The transaction valued at 52,780 led to the insider holds 86,638 shares of the business.
Hutson Nancy J bought 7,000 shares of BCRX for $52,584 on Dec 13 ’24. On Jun 24 ’24, another insider, McKee Amy E, who serves as the Director of the company, sold 8,600 shares for $6.32 each. As a result, the insider received 54,352 and left with 27,831 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCRX now has a Market Capitalization of 1576282112 and an Enterprise Value of 2088403840. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.82. Its current Enterprise Value per Revenue stands at 5.062 whereas that against EBITDA is -65.383.
Stock Price History:
Over the past 52 weeks, BCRX has reached a high of $8.88, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is 0.50%, while the 200-Day Moving Average is calculated to be 8.93%.
Shares Statistics:
For the past three months, BCRX has traded an average of 2.18M shares per day and 2560090 over the past ten days. A total of 207.12M shares are outstanding, with a floating share count of 195.42M. Insiders hold about 5.66% of the company’s shares, while institutions hold 82.08% stake in the company. Shares short for BCRX as of 1735603200 were 15721517 with a Short Ratio of 7.22, compared to 1732838400 on 19362152. Therefore, it implies a Short% of Shares Outstanding of 15721517 and a Short% of Float of 7.6499999999999995.
